Using NOVAREL®

You’ve been prescribed NOVAREL®, a human chorionic gonadotropin (hCG), which is usually used in conjunction with a gonadotropin, such as BRAVELLE® (urofollitropin for injection, purified), MENOPUR® (menotropins for injection, USP) , or REPRONEX® (menotropins for injection, USP). NOVAREL® is administered through intramuscular injection and is used during ovulation induction therapy to trigger egg release.

It’s natural to have concerns about your infertility treatment, so we’ve provided practical and detailed information about NOVAREL® that you may need, including:

Prescribing Information

Learn about possible side effects, contraindications, and other information found within the full Prescribing Information.

Injecting NOVAREL®

Access helpful instructions for administering your intramuscular injections.

NOVAREL® FAQs

Find the answers to our most frequently asked questions about NOVAREL®.

This information is provided as an educational service; if you have any questions, please don't hesitate to call your doctor or nurse.

NOVAREL® is indicated for induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately pretreated with urofollitropins or human menotropins.

Important Safety Information:
NOVAREL® should be used in conjunction with urofollitropin or human menopausal gonadotropins only by physicians thoroughly experienced with infertility treatment. Principal serious adverse reactions are: OHSS; enlargement or rupture of ovarian cysts with resultant hemoperitoneum; multiple births; and arterial thromboembolism. NOVAREL® is contraindicated in women with precocious puberty, androgen-dependent neoplasm, and prior allergic reaction to HCG. HCG may cause fetal harm when administered to a pregnant woman. Combined HCG/PMS (pregnant mare’s serum) therapy has been noted to induce high incidences of external congenital anomalies in the offspring of mice, in a dose-dependent manner. The potential extrapolation to humans has not been determined.

Click here to see Full Prescribing Information for NOVAREL®.


Previous:
NOVAREL®
Next:
Injecting NOVAREL®